Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 19/20 | 1.00 |
| ▸ | BECN1 | Q14457 | 10/20 | 1.00 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23269003 | 0.90 | BCL2 (1.00) | BCL2BECN1CACNA1H | |
| SCHEMBL23268921 | 0.87 | BCL2 (1.00) | BCL2BECN1 | |
| SCHEMBL23268984 | 0.86 | BCL2 (1.00) | BCL2BECN1 | |
| SCHEMBL23268937 | 0.86 | BCL2 (1.00) | BCL2BECN1 | |
| SCHEMBL23269404 | 0.85 | BCL2 (1.00) | BCL2BECN1CACNA1H | |
| SCHEMBL23269400 | 0.85 | BCL2 (0.75) | BCL2BECN1CACNA1H | |
| SCHEMBL23269366 | 0.84 | BCL2 (1.00) | BCL2BECN1 | |
| SCHEMBL23268996 | 0.83 | BCL2 (1.00) | BCL2BECN1 | |
| SCHEMBL23269399 | 0.83 | BCL2 (1.00) | BCL2BECN1 | |
| SCHEMBL23268899 | 0.81 | BCL2 (1.00) | BCL2BECN1CACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203020-A1 | Small molecule inducers of autophagy | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-06-29 | — | — | US | disclosed |
| US-11325898-B2 | Small molecule inducers of autophagy | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-05-10 | — | — | US | disclosed |
| US-20210115024-A1 | Small molecule inducers of autophagy | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325898-B2 | Small molecule inducers of autophagy | BECN1, SQSTM1, MAP1LC3A | BCL2 11/4885BECN1 1/4885CACNA1H 3432/4885 |
| US-20210115024-A1 | Small molecule inducers of autophagy | BECN1, SQSTM1, MAP1LC3A | BCL2 11/4885BECN1 1/4885CACNA1H 3432/4885 |
| US-20230203020-A1 | Small molecule inducers of autophagy | BECN1, SQSTM1, MAP1LC3A | BCL2 11/4885BECN1 1/4885CACNA1H 3432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.